Biology. Agility. Analytics.

Our relentless dedication to accuracy, timeliness and regulatory rigor enables your therapeutic innovations to reach patients faster.

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

    Services Delivered Scientist to Scientist

    Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.

    biomarkers

    Biomarkers

    immunogenicity

    Immunogenicity

    pharmacokinetics

    Pharmacokinetics & Pharmacodynamics (PK/PD)

    cell-based-assays

    Cell-Based Assays

    Solutions Enabled by World-Leading Expertise

    Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for therapeutics innovation.

    biosimilars

    Biosimilars

    gene-therapy

    Gene Therapy

    antibody-drug-conjugates

    Antibody Drug Conjugates (ADCs)

    immuno-oncology

    Immuno-oncology

    Dec-2021-Webinar
    SCIENCE ON-DEMAND

    ADA Assessment for Cell Therapies

    Cell therapies are emerging and evolving as promising therapies for a variety of disease indications. The ability to detect anti-drug antibodies (ADA) is important for patients receiving cell-based therapies. However, approaches to detecting ADAs against cell-surface biotherapeutics vary utilizing either traditional ligand binding assays or cell-based binding assays. Both ADA assay approaches have been utilized but there is no current regulatory guidance on which format is more appropriate for these therapeutics. In this presentation, we will discuss the challenges of both approaches and current industry practices.

    Watch Now

    The Bioagilytix Perspective

    Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.

    resource center

    Visit Resource Center

    global bioanalytical services cro durham boston hamburg

    ADVANCED BIOANALYTICAL LAB FACILITIES TO SUPPORT ALL PHASES OF DRUG DEVELOPMENT.